Safety and aesthetic outcomes of SERASYNTH

Julia Gruber, Paul Schlagnitweit, Georgios Koulaxouzidis

Abstract read

In one paragraph

Article in JPRAS open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Serasynth Mesh BR Pocket in Prepectoral Direct-to-implant and Tissue-expander Breast Reconstruction: A Retrospective Single-center Analysis.Plastic and reconstructive surgery. Global open · 2026
Article
Complication rate after implant-based breast-reconstruction with support of a synthetic non-resorbable titanized polypropylene mesh (TiLOOP® Bra): Analysis of the 2-year follow up from the prospective multicentre PRO-BRA trial.JPRAS open · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julia GruberDepartment of Plastic, Aesthetic and Reconstructive Surgery, Sisters of Mercy Hospital Linz, Austria.

Paul SchlagnitweitDepartment of Plastic, Aesthetic and Reconstructive Surgery, Sisters of Mercy Hospital Linz, Austria.

Georgios KoulaxouzidisDepartment of Plastic, Aesthetic and Reconstructive Surgery, Sisters of Mercy Hospital Linz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bilateral mastectomy for both therapeutic and prophylactic reasons is becoming increasingly important. To achieve good results after mastectomy, synthetic meshes are often used as an alternative to acellular dermal matrices (ADMs). The aim of this study is to analyze the results of subcutaneous mastectomies and direct-to-implant breast reconstruction using SERASYNTH Methods: In this work, data from mastectomies ( Results: Major complications occurred in 15.6% ( Conclusion: The application of the absorbable polymer poly-p-dioxanone SERASYNTH

Indexed as

Direct-to-implant breast reconstructionMesh resorption timeProphylactic mastectomySerasynth meshSeroma

Identifiers

PMID37745008

DOI10.1016/j.jpra.2023.08.001

PMCPMC10514390

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.